Rua Life Sciences PLC (RUA) - Total Assets

Latest as of September 2025: GBX9.12 Million GBX ≈ $1.11K USD

Based on the latest financial reports, Rua Life Sciences PLC (RUA) holds total assets worth GBX9.12 Million GBX (≈ $1.11K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Rua Life Sciences PLC - Total Assets Trend (1994–2025)

This chart illustrates how Rua Life Sciences PLC's total assets have evolved over time, based on quarterly financial data. Also see Rua Life Sciences PLC market capitalisation for the company's overall valuation and market capitalisation.

Rua Life Sciences PLC - Asset Composition Analysis

Current Asset Composition (September 2025)

Rua Life Sciences PLC's total assets of GBX9.12 Million consist of 59.2% current assets and 40.8% non-current assets. Review RUA total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	35.7%
Accounts Receivable	GBX1.25 Million	13.7%
Inventory	GBX894.00K	9.8%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX348.00K	3.8%
Goodwill	GBX301.00K	3.3%

Asset Composition Trend (1994–2025)

This chart illustrates how Rua Life Sciences PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Rua Life Sciences PLC stock price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Rua Life Sciences PLC's current assets represent 59.2% of total assets in 2025, an increase from 49.2% in 1994.
Cash Position: Cash and equivalents constituted 35.7% of total assets in 2025, up from 0.1% in 1994.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 19.0% in 1994.
Asset Diversification: The largest asset category is accounts receivable at 13.7% of total assets.

Rua Life Sciences PLC Competitors by Total Assets

Key competitors of Rua Life Sciences PLC based on total assets are shown below.

Company	Country	Total Assets
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$96.98 Million
Cochlear Ltd AU:COH	Australia	AU$2.83 Billion
COCHLEAR LTD ADR 1/2/O.N. F:OC50	Germany	€2.83 Billion
Lumexa Imaging Holdings, Inc. Common Stock NASDAQ:LMRI	USA	$1.81 Billion
L&C Bio Co. Ltd KQ:290650	Korea	₩497.94 Billion
Eurobio Scientific SA PA:ALERS	France	€259.11 Million
Profound Medical Corp TO:PRN	Canada	CA$62.28 Million
EBR Systems Inc AU:EBR	Australia	AU$97.29 Million

Rua Life Sciences PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.64	6.47	1.67
Quick Ratio	3.87	5.25	1.53
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX4.23 Million	GBX5.00 Million	GBX561.00K

Rua Life Sciences PLC - Advanced Valuation Insights

This section examines the relationship between Rua Life Sciences PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.39
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	-1.5%
Total Assets	GBX9.12 Million
Market Capitalization	$211.43K USD

Valuation Analysis

Below Book Valuation: The market values Rua Life Sciences PLC's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Rua Life Sciences PLC's assets decreased by 1.5% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Rua Life Sciences PLC (1994–2025)

The table below shows the annual total assets of Rua Life Sciences PLC from 1994 to 2025.

Year	Total Assets	Change
2025-09-30	GBX9.12 Million ≈ $1.11K	-1.49%
2025-03-31	GBX9.26 Million ≈ $1.13K	+13.29%
2024-03-31	GBX8.17 Million ≈ $993.93	+44.25%
2023-03-31	GBX5.66 Million ≈ $689.02	-25.74%
2022-03-31	GBX7.63 Million ≈ $927.86	-24.90%
2021-03-31	GBX10.15 Million ≈ $1.24K	+307.18%
2020-03-31	GBX2.49 Million ≈ $303.45	-19.52%
2019-03-31	GBX3.10 Million ≈ $377.06	+186.15%
2018-03-31	GBX1.08 Million ≈ $131.77	-4.44%
2017-03-31	GBX1.13 Million ≈ $137.89	-15.16%
2016-03-31	GBX1.34 Million ≈ $162.53	-24.91%
2015-03-31	GBX1.78 Million ≈ $216.46	-8.76%
2014-03-31	GBX1.95 Million ≈ $237.24	-36.30%
2013-03-31	GBX3.06 Million ≈ $372.45	-14.16%
2012-03-31	GBX3.57 Million ≈ $433.87	-5.71%
2011-03-31	GBX3.78 Million ≈ $460.16	-37.34%
2010-03-31	GBX6.04 Million ≈ $734.41	-10.22%
2009-03-31	GBX6.72 Million ≈ $817.99	-14.27%
2008-03-31	GBX7.84 Million ≈ $954.14	+113.27%
2007-03-31	GBX3.68 Million ≈ $447.38	-36.16%
2006-03-31	GBX5.76 Million ≈ $700.83	-4.02%
2005-03-31	GBX6.00 Million ≈ $730.15	-25.03%
2004-03-31	GBX8.01 Million ≈ $973.98	-13.37%
2003-03-31	GBX9.24 Million ≈ $1.12K	-81.08%
2002-03-31	GBX48.84 Million ≈ $5.94K	+26.92%
2001-03-31	GBX38.48 Million ≈ $4.68K	-13.27%
2000-03-31	GBX44.37 Million ≈ $5.40K	+717.20%
1999-03-31	GBX5.43 Million ≈ $660.55	+39.10%
1998-03-31	GBX3.90 Million ≈ $474.88	-16.28%
1997-03-31	GBX4.66 Million ≈ $567.23	+125.87%
1996-03-31	GBX2.06 Million ≈ $251.13	+6.17%
1995-03-31	GBX1.94 Million ≈ $236.53	-6.49%
1994-03-31	GBX2.08 Million ≈ $252.95	--

About Rua Life Sciences PLC

LSE:RUA UK Medical Devices

Market Cap

$211.43K

GBX1.74 Billion GBX

Market Cap Rank

#31325 Global

#1022 in UK

Share Price

GBX28.00

Change (1 day)

+0.00%

52-Week Range

GBX11.00 - GBX28.50

All Time High

GBX176.50